1,131 results on '"van den Bosch F"'
Search Results
2. Possible Seismic Source Mechanism of the Catastrophic Tsunamigenic Earthquake on May 9, 1877 in Northwestern Chile
3. OP0085 CLINICAL FEATURES OF PATIENTS WITH SpA, WITH OR WITHOUT IBD: RESULTS FROM THE METEOR COHORT
4. POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
5. POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY
6. POS0443 PREVALENCE OF EARLY AXIAL SPONDYLOARTHRITIS IN THE Be-GIANT COHORT BASED ON THE ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS
7. POS0421 MRI-BASED SYNTHETIC CT IS SUPERIOR TO CONVENTIONAL MRI FOR THE DETECTION OF STRUCTURAL LESIONS IN POSTPARTUM WOMEN AFTER 5 YEAR FOLLOW-UP
8. NUMERICAL SIMULATION OF A CATASROPHIC EARTHQUAKE AND STRONG TSUNAMI OF APRIL 1, 2014 NEAR THE NORTHWESTERN PART OF THE CHILEAN COAST
9. Translating surveillance data into incidence estimates
10. Early detection surveillance for Huanglongbing in a plantation; from theory to practice
11. The clustering of galaxies in the sdss-iii baryon oscillation spectroscopic survey: The low-redshift sample
12. Mergers in λCDM: Uncertainties in theoretical predictions and interpretations of the merger rate
13. Transmission Rates and Adaptive Evolution of Pathogens in Sympatric Heterogeneous Plant Populations
14. A Model for the Evolution of Pathogen-Induced Leaf Shedding
15. POS0671 VALIDATION OF TWO RESPONSE AND ONE STATUS MEASURES OF THE ASAS HEALTH INDEX VERSUS EXTERNAL ANCHORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
16. AB1082 EARLY CLINICAL RESPONSE AS A PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS AND TNFI-IR RECEIVING GUSELKUMAB (COSMOS)
17. POS1334 WORK PARTICIPATION AND WORK DISABILITY IN BELGIAN PATIENTS WITH SYSTEMIC SCLEROSIS
18. POS1107 BIMEKIZUMAB ACHIEVED SUSTAINED IMPROVEMENTS IN EFFICACY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, REGARDLESS OF PRIOR TNF INHIBITOR TREATMENT: WEEK 52 POOLED RESULTS FROM TWO PHASE 3 STUDIES
19. POS1108 EFFICACY OF UPADACITINIB IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN EARLY VERSUS ESTABLISHED DISEASE
20. OP0062 EULAR POINTS TO CONSIDER FOR THE DEFINITION OF CLINICAL AND IMAGING FEATURES SUSPICIOUS FOR PROGRESSION TO PSORIATIC ARTHRITIS
21. POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS
22. AB0651 INDIRECT HEALTH RELATED COST IN pSS PATIENTS IN RELATION TO SYMPTOM BASED ENDOTYPES
23. AB1018 BASELINE CHARACTERISTICS OF AN EARLY SPONDYLOARTHRITIS COHORT IN HONG KONG
24. POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
25. OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS
26. POS0244 PROTOCOL VIOLATION IN A TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: DATA FROM THE OPEN-LABEL, PRAGMATIC, CLUSTER-RANDOMISED TICOSPA TRIAL
27. POS0672 RHEUMATOLOGISTS OVERCALL SACROILIITIS ON X-RAY AND MRI IN AXIAL SPONDYLOARTHRITIS PATIENTS: DATA FROM THE BELGIAN INFLAMMATORY ARTHRITIS AND SPONDYLITIS COHORT (BE-GIANT)
28. Diagnostic value of MRI features of sacroiliitis in juvenile spondyloarthritis
29. E-book: Reumatologie – Uitgave 2023
30. Amélioration des signes et symptômes chez des patients atteints de spondyloarthrite axiale radiographique traités par bimékizumab : résultats à 24 semaines d’une étude de phase III, multicentrique, randomisée et contrôlée par placebo
31. Efficacité d’upadacitinib chez des patients atteints de spondyloarthrite axiale non radiographique en fonction des signes objectifs d’inflammation à l’inclusion
32. Efficacité et tolérance à long terme de l’upadacitinib chez les patients présentant un rhumatisme psoriasique réfractaire aux traitements biologiques : résultats à 2 ans de l’étude de phase III SELECT-PsA 2
33. MR signal in the sacroiliac joint space in spondyloarthritis: a new sign
34. Early detection surveillance for an emerging plant pathogen: a rule of thumb to predict prevalence at first discovery
35. The Dependence of Low Redshift Galaxy Properties on Environment
36. MRI of the SI joints commonly shows non-inflammatory disease in patients clinically suspected of sacroiliitis
37. A generic risk-based surveying method for invading plant pathogens
38. Introduction: Perspectives on Porter
39. The value of volunteer surveillance for the early detection of biological invaders
40. Response to: ‘Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease’ by Orlando et al
41. Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
42. Possible Seismic Source Mechanism of the Catastrophic Tsunamigenic Earthquake on May 9, 1877 in Northwestern Chile.
43. Modelling transmission characteristics and epidemic development of the tospovirus–thrip interaction
44. POS0299 EFFECT OF SECUKINUMAB ON RADIOGRAPHIC PROGRESSION AND INFLAMMATION IN SACROILIAC JOINTS AND SPINE IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR IMAGING OUTCOMES FROM A PHASE III RANDOMISED TRIAL
45. OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY
46. OP0216 DEVELOPMENT, REFINEMENT AND WEIGHTING OF CANDIDATE CRITERIA FOR AXIAL DISEASE IN JUVENILE SPONDYLOARTHRITIS: AN INTERNATIONAL COLLABORATION
47. POS1041 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 2 STUDY
48. OP0016 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
49. POS1451 DISCRIMINATORY CAPACITY OF THE ASAS HEALTH INDEX IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED IN A TIGHT CONTROL SETTING VERSUS STANDARD OF CARE
50. POS0161 WORK STATUS IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES: RESULTS OF A BELGIAN COMPARATIVE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.